Benicar Hct (olmesartan Medoxomil recalls
The FDA has published 3 recalls involving Benicar Hct (olmesartan Medoxomil since 2014. The latest was reported on 6 Aug 2014. Most were for temperature abuse. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 6 Aug 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why benicar hct (olmesartan medoxomil is recalled
Companies
By year
All benicar hct (olmesartan medoxomil recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Benicar HCT Tablets (olmesartan recalled by Daiichi Sankyo Pharma | Daiichi Sankyo Pharma Development | Temperature Abuse | Nationwide |
| Drug | CLASS II | Benicar HCT Tablets (olmesartan medoxomil recalled | Daiichi Sankyo Pharma Development | Temperature Abuse | Nationwide |
| Drug | CLASS II | Benicar HCT Tablets (olmesartan recalled by Daiichi Sankyo Pharma | Daiichi Sankyo Pharma Development | Temperature Abuse | Nationwide |
Should you stop taking Benicar Hct (olmesartan Medoxomil?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.